Michael R. Eber
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
-
- Urinary Tract Infections Management 3
-
- Health Systems, Economic Evaluations, Quality of Life 3
- Co-authors
- Ramanan Laxminarayan (5 shared papers)Marin L. Schweizer (3 shared papers)Eli N. Perencevich (3 shared papers)Michelle Shardell (2 shared papers)Nikolay Braykov (2 shared papers)Eili Klein (1 shared paper)Daniel J. Morgan (1 shared paper)Marc Hoffmann (1 shared paper)
- Journals
- Infection Control and Hospital Epidemiology (3 papers)Antimicrobial Resistance and Infection Control (1 paper)Journal of Risk and Uncertainty (1 paper)American Heart Journal (1 paper)Journal of Benefit-Cost Analysis (1 paper)
- Partner nations
- United StatesIndiaFrance
In The Last Decade
Michael R. Eber
11 papers receiving 423 citations
Peers
Comparison fields: 5 of 82
- Applied Microbiology and Biotechnology 100
- Molecular Medicine 137
- Critical Care and Intensive Care Medicine 55
- Clinical Biochemistry 58
- Endocrinology 39
Countries citing papers authored by Michael R. Eber
This map shows the geographic impact of Michael R. Eber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Eber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Eber more than expected).
Fields of papers citing papers by Michael R. Eber
This network shows the impact of papers produced by Michael R. Eber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Eber. The network helps show where Michael R. Eber may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael R. Eber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 137 | |
| 2 | 2011 | 126 | |
| 3 | 2013 | 69 | |
| 4 | 2011 | 37 | |
| 5 | 2009 | 24 | |
| 6 | 2013 | 17 | |
| 7 | 2013 | 6 | |
| 8 | 2022 | 6 | |
| 9 | 2023 | 4 | |
| 10 | 2021 | 3 | |
| 11 | 2015 | 2 |
About Michael R. Eber
Michael R. Eber is a scholar working on Epidemiology, Economics and Econometrics, Infectious Diseases, Applied Microbiology and Biotechnology and General Health Professions, having authored 11 papers that have together received 431 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Urinary Tract Infections Management (3 papers), Antibiotic Use and Resistance (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Climate Change and Health Impacts (2 papers), Antibiotic Resistance in Bacteria (2 papers), Medical Coding and Health Information (1 paper) and Cardiac Arrhythmias and Treatments (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (100 citations), Molecular Medicine (137 citations), Critical Care and Intensive Care Medicine (55 citations), Clinical Biochemistry (58 citations) and Endocrinology (39 citations). Michael R. Eber has collaborated with scholars based in United States, India and France. Frequent co-authors include Ramanan Laxminarayan, Marin L. Schweizer, Eli N. Perencevich, Michelle Shardell, Nikolay Braykov, Eili Klein, Daniel J. Morgan, Marc Hoffmann, Bala Hota and Jon P. Furuno. Their work appears in journals such as Infection Control and Hospital Epidemiology, Antimicrobial Resistance and Infection Control, Journal of Risk and Uncertainty, American Heart Journal and Journal of Benefit-Cost Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.